About: Micelle-associated protein in epoetin formulations: aA risk factor for immunogenicity?

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Micelle-associated protein in epoetin formulations: aA risk factor for immunogenicity? Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 December 2003

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в грудні 2003 (uk) مقالة علمية تنشرت ف 1 دجنبر 2003 (ary) im Dezember 2003 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu n'avientu de 2003 (ast) scientific article published on 01 December 2003 (en)
publication date	wds:Q75269185-C056654C-9A9C-46A0-A9EE-703AA5804397
publication date	2003-12-01 00:00:00Z (xsd:dateTime)
cites work	wds:Q75269185-01532493-C3D4-4EC6-B935-E022CDE20E63 wds:Q75269185-059B6DCF-DFF9-4B2A-8DA1-58550822A443 wds:Q75269185-237D399E-5B55-4AD9-9D35-13696E2D5B5F wds:Q75269185-2BADA1F8-1FFB-4404-92AD-055C415C2D3E wds:Q75269185-3FDDADEB-34F3-4B23-A20C-F8CC36DC7C91 wds:Q75269185-54B2E1B6-7162-47E5-8743-D6011CC170D4 wds:Q75269185-56885582-6484-4DE8-9F1F-C6FAD484FA6A wds:Q75269185-60F7DA71-1585-4134-A92B-CB0D59E543A2 wds:Q75269185-970195DE-5A6E-4F1D-8D4B-AAC277D4708B wds:Q75269185-A609617C-9810-4527-9961-6B0C04B88601 wds:Q75269185-B7C2A6C3-B861-4596-9EB9-3B5710F7A189 wds:Q75269185-C9A6A422-2BAB-4D42-8FDD-FB6248583620 wds:Q75269185-F3F029E0-34AD-45F8-92B8-14F9CEEA068D
cites work	Immunogenicity and allergenic potential of animal and human insulins Role of aggregated human growth hormone (hGH) in development of antibodies to hGH Protein aggregates seem to play a key role among the parameters influencing the antigenicity of interferon alpha (IFN-alpha) in normal and transgenic mice Pure red-cell aplasia and recombinant erythropoietin Immune responses to therapeutic proteins in humans--clinical significance, assessment and prediction Pharmaceutical biotechnology products approved within the European Union Pure red-cell aplasia and antierythropoietin antibodies in patients treated with recombinant erythropoietin Bioequivalence and the immunogenicity of biopharmaceuticals Uncertainties - discrepancies in immunology Antibodies against rHuEPO: native and recombinant Interferon immunogenicity: technical evaluation of interferon-alpha 2a. CMC of polysorbates Drug-induced autoimmune red-cell aplasia
author name string	wds:Q75269185-0A1D7FB4-E7CE-41DB-BDD5-34B9856DF253 wds:Q75269185-33DBEE97-BF03-4962-A85B-CE8D183A8A97 wds:Q75269185-823B7D94-16A2-4B9E-9556-564AC88B91C5
author name string	Huub Schellekens Daan J A Crommelin Suzanne Hermeling
rdfs:label	Micelle-associated protein in epoetin formulations: aA risk factor for immunogenicity? (en) Micelle-associated protein in epoetin formulations: aA risk factor for immunogenicity? (nl)
skos:prefLabel	Micelle-associated protein in epoetin formulations: aA risk factor for immunogenicity? (en) Micelle-associated protein in epoetin formulations: aA risk factor for immunogenicity? (nl)
name	Micelle-associated protein in epoetin formulations: aA risk factor for immunogenicity? (en) Micelle-associated protein in epoetin formulations: aA risk factor for immunogenicity? (nl)
author	wds:Q75269185-D06DF115-17F2-43D0-9391-6437FC595214
author	Wim Jiskoot
title	wds:Q75269185-0461E393-1DD8-4EBC-9EEE-0382991A9569
title	Micelle-associated protein in epoetin formulations: aA risk factor for immunogenicity? (en)
page(s)	wds:Q75269185-A0D076B3-D914-4565-BD06-D98B895F766A
page(s)	1903-1907
instance of	wds:Q75269185-F73B57DF-EB37-476E-8384-457533B4B9E6
instance of	scholarly article
PubMed ID	wds:Q75269185-4C5C5401-023B-48DD-B0D9-D8239A9FAC6B
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/14725351
PubMed ID	14725351
published in	wds:Q75269185-C42AACCC-53C5-4F7D-BD03-02455D78A5DA
published in	Pharmaceutical Research
issue	wds:Q75269185-3A13F92A-1BF8-41DC-A9F8-31BB90CFB39E
volume	wds:Q75269185-2C281903-5E29-4988-97CA-D1F31AD48893
issue	12
volume	20
DOI	wds:Q75269185-BC845233-E9F9-49EB-8E80-5D687E6BEE59
DOI	http://dx.doi.org/10.1023/B:PHAM.0000008034.61317.02
DOI	10.1023/B:PHAM.0000008034.61317.02
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q75269185
is cites work of	Strategies for the assessment of protein aggregates in pharmaceutical biotech product development Effects of protein aggregates: an immunologic perspective Tungsten-induced denaturation and aggregation of epoetin alfa during primary packaging as a cause of immunogenicity Eprex-associated pure red cell aplasia and leachates Protein drug stability: a formulation challenge Biopharmaceutical benchmarks 2006. Immunogenicity of therapeutic proteins: influence of aggregation Quality of original and biosimilar epoetin products Native-like aggregates of factor VIII are immunogenic in von Willebrand factor deficient and hemophilia a mice Insights into protein-polysorbate interactions analysed by means of isothermal titration and differential scanning calorimetry. Reaction to the paper: interaction of polysorbate 80 with erythropoietin: a case study in protein-surfactant interactions. Interaction of polysorbate 80 with erythropoietin: a case study in protein-surfactant interactions. Antibody-mediated pure red cell aplasia in chronic kidney disease patients receiving erythropoiesis-stimulating agents: new insights Biosimilar therapeutics-what do we need to consider? Expression and analysis of the glycosylation properties of recombinant human erythropoietin expressed in Pichia pastoris Competition Between Biosimilars and Patented Biologics: Learning from European and Japanese Experience. Antigenic differences between AS03 adjuvanted influenza A (H1N1) pandemic vaccines: implications for pandemrix-associated narcolepsy risk. Quality and Batch-to-Batch Consistency of Original and Biosimilar Epoetin Products. Cellular localization and detergent dependent oligomerization of rice allene oxide synthase-1. Immunogenicity of Biotherapeutics: Causes and Association with Posttranslational Modifications Antibody-mediated pure red cell aplasia (PRCA) on switching from darbepoetin alfa to epoetin beta: what are the implications? Understanding the immunogenicity and antigenicity of nanomaterials: Past, present and future Sensitive spectroscopic detection of large and denatured protein aggregates in solution by use of the fluorescent dye Nile red. Scientific considerations for generic synthetic salmon calcitonin nasal spray products How bio-questionable are the different recombinant human erythropoietin copy products in Thailand? The Safety of Erythropoiesis-Stimulating Agents for the Treatment of Anemia Resulting from Chronic Kidney Disease Pure red cell aplasia induced by epoetin zeta Sensitive and molecular size-selective detection of proteins using a chip-based and heteroliganded gold nanoisland by localized surface plasmon resonance spectroscopy Follow-on biologics in oncology - the need for global and local regulations. How Full-Length FVIII Benefits from Its Heterogeneity - Insights into the Role of the B-Domain Modulating the immune system through nanotechnology. Self-associated submicron IgG1 particles for pulmonary delivery: effects of non-ionic surfactants on size, shape, stability, and aerosol performance

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 190 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software